...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: from IR "Hepalink does not own Zenith shares."

Thanks Tada, i wonder its webcast or not, I could find anything on the website

Share
New Message
Please login to post a reply